Stay updated on Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page.
Latest updates to the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check8 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference2%
- Check58 days agoChange DetectedThe website has been updated from version v2.12.1 to v2.12.2.SummaryDifference0.1%
- Check80 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page.